Tumours reprogram nylon synthesis


The redesigned enzyme can produce a precursor to adipic acid - a chemical used to make nylon © NPG

Cancer mutations have inspired a redesign of an enzyme to catalyse a key step in the bio-based production of adipic acid, a precursor to nylon. Currently, 5.5 million tonnes of nylon are manufactured worldwide every year for uses as diverse as clothing, carpets and toothbrush bristles.

Developing a clean, fully biological adipic acid synthesis would dramatically reduce costs and the need for fossil fuels or harsh solvents. As a result, industry is keen to use enzymes to catalyse chemical reactions to synthesise target molecules.

Cancers are notorious for having rogue enzymes, possessing mutations and catalysing alternative reactions to their healthy, wild type counterparts. Hai Yan’s team of cancer researchers at the Duke University Medical Center in North Carolina, US, looked to mutant enzymes to find new, industrially relevant biosynthetic pathways. They discovered an isocitrate dehydrogenase (IDH) enzyme that could catalyse the reaction of 2-oxoglutarate to (R)-2-hydroxyglutarate – a product with a five-carbon backbone that is just one carbon shorter than the adipic acid precursor (R)‑2‑hydroxyadipate.

The team used structural sequence homology to apply the same mutations found in the mutant IDH to homoisocitrate dehydrogenase (HIDH), which can catalyse reactions of six-carbon backbone structures. The new, redesigned HIDH enzyme can catalyse the reduction of 2‑oxoadipate to the industrially useful (R)‑2‑hydroxyadipate. The HIDH mutant has high substrate specificity and excellent enantioselectivity delivering enantiomeric excesses of >99%. ‘This is exciting not only because we have a better understanding of these enzymes, but because we have an enzyme that has never been produced before and with a useful proposed function,’ says lead author Zach Reitman. ‘Hopefully, this is the last piece of the jigsaw puzzle for a promising fully biological route to adipic acid.’

Ian Mills, from the Centre for Molecular Medicine Norway (NCMM), says this study is an interesting illustration of translational cancer research. ‘Re‑engineering enzymes expressed in primitive organisms, such as yeast or bacteria, to provide alternative routes to generate chemicals to sustain the manufacturing industry has the potential, if scaleable and efficient, to lessen the dependency on conventional catalysis and fossil fuels,’ Mills says. ‘Increased dialogue between cancer biologists and chemists will be critical to catalysing the rapid transfer of data from field-to-field and the timely exploration of new possibilities.’

Yan adds: ‘We are thrilled that a common gene mutation of a devastating disease can be harnessed for beneficial uses.’ The next steps will be to produce all of the enzymes required for this biological adipic acid route in the same microorganism, optimise the pathway and scale-up the process for industry.

Related Content

China’s nitrous oxide emissions to triple by 2020

7 May 2014 Research

news image

Chemical is biggest threat to the recovery of the ozone layer and a potent greenhouse gas too

Redesigning nature's catalysts

30 June 2011 Premium contentFeature

news image

Harnessing the power of enzymes to perform reactions outside their normal abilities is adding powerful tools to the synthetic...

Most Read

Antimicrobial resistance will kill 300 million by 2050 without action

16 December 2014 News and Analysis

news image

UK report says resistance will cost global economy $100 trillion

Cutting edge chemistry in 2014

10 December 2014 Research

news image

We take a look back at the year's most interesting chemical science stories

Most Commented

Smart skin for prosthetic limbs senses heat and touch

12 December 2014 Research

news image

Ultra-thin plastic skin can bend and flex without affecting the skin's ability to detect stimuli

Chemistry behind the ‘blue man’ unlocked

1 November 2012 Research

news image

Biochemical model suggests that silver ions, not nanoparticles, cause a rare skin complaint